Physician profile
Brian E Louie
NPI 1982767711
$6,494.61
in general payments reported to CMS, 2019-2025
18 companies · $1,994 in 2025
The $1,994 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $936 · 2020: $2,108 · 2021: $95.49 · 2022: $212 · 2023: $734 · 2024: $415 · 2025: $1,994.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,191 · Travel and Lodging: $951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,191.07 |
| Travel and Lodging | $951.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $1,955.00 | 2020 | |
| Boston Scientific Corporation | $1,661.66 | 2019-2025 | General - Endochoice, Overstitch Endoscopic Suturing System, Apollo Esg Nxt System |
| Intuitive Surgical, INC. | $775.49 | 2019-2025 | |
| Medtronic, INC. | $381.24 | 2022-2023 | Endoflip |
| Enterra Medical, INC. | $351.87 | 2023-2025 | |
| Atricure, INC. | $292.82 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $226.92 | 2025 | Imfinzi |
| Ethicon INC. | $178.78 | 2023 | Monarch Platform |
| Pinnacle Biologics, INC | $156.12 | 2019-2024 | Photofrin |
| Penumbra, INC. | $139.65 | 2025 | Indigo System |
| Mauna Kea Technologies, INC. | $116.07 | 2024 | |
| Erbe USA INC | $105.21 | 2020-2025 | Vio3, Vio 3 |
| Endogastric Solutions, INC | $59.50 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $35.84 | 2023-2024 | Opdivo |
| Davol INC. | $23.72 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $18.24 | 2023 | Linx Reflux Management System |
| Covidien LP | $16.48 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Louie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.